UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Applied Capital LLC FL

Applied Capital LLC FL boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,463 shares of the healthcare conglomerate’s stock after purchasing an additional 260 shares during the period. UnitedHealth Group makes up 1.8% of Applied Capital LLC FL’s portfolio, making the stock its 18th biggest position. Applied Capital LLC FL’s holdings in UnitedHealth Group were worth $2,208,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in UNH. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter valued at $5,802,231,000. International Assets Investment Management LLC boosted its stake in UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after acquiring an additional 2,348,107 shares during the last quarter. Jennison Associates LLC boosted its stake in UnitedHealth Group by 49.3% during the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after acquiring an additional 1,195,352 shares during the last quarter. California Public Employees Retirement System lifted its position in shares of UnitedHealth Group by 35.9% in the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after buying an additional 815,822 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado lifted its position in shares of UnitedHealth Group by 3,464.9% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after buying an additional 802,160 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UNH stock opened at $498.13 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $458.47 billion, a P/E ratio of 30.45, a P/E/G ratio of 1.48 and a beta of 0.60. The firm has a 50 day simple moving average of $498.40 and a 200 day simple moving average of $501.35.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the company earned $6.26 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.69%. The ex-dividend date of this dividend was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. Bank of America reiterated a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Robert W. Baird began coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price objective on the stock. TD Cowen lowered their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.